SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Mar-22 8:00 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 06-Mar-22 | Grant | 35,885 | -- | -- | 19% 187.43K to 223.31K | |
10-Dec-21 8:05 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 10-Dec-21 | Grant | 35,885 | -- | -- | 24% 151.54K to 187.43K | |
06-Mar-20 4:10 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 06-Mar-20 | Grant | 35,885 | -- | -- | 31% 115.66K to 151.54K | |
27-Dec-19 7:01 AM View: | Brainstorm Cell Therapeutic... (BCLI) | 24-Dec-19 | Market Purchase | 3,000 | $3.88 | $11,640.00 | 3% 112.66K to 115.66K | (5%) |
08-Mar-19 5:02 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 06-Mar-19 | Grant | 35,885 | -- | -- | 47% 76.77K to 112.66K | |
19-Mar-18 4:05 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 15-Mar-18 | Grant | 5,000 | $3.60 | $17,997.00 | 14% 35.88K to 40.88K | (80%) |
26-Mar-18 4:49 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 06-Mar-18 | Grant | 35,885 | -- | -- | 88% 40.88K to 76.77K | |
06-Mar-17 4:05 PM View: | Brainstorm Cell Therapeutic... (BCLI) | 06-Mar-17 | Grant | 35,885 | -- | -- | 100% 0 to 35.88K |